Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Clin Infect Dis ; 59(10): e142-9, 2014 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-25028463

RESUMO

BACKGROUND: Rapid sputum culture conversion at 2 months indicates the sterilizing capacity and potential of regimens to shorten duration of tuberculosis treatment. We compared results of sputum culture conversion by moxifloxacin and control regimens and identified factors affecting sputum culture positivity after 2 months of treatment. METHODS: Human immunodeficiency virus-uninfected adults with newly diagnosed smear-positive pulmonary tuberculosis were randomized to receive a 3- or 4-month moxifloxacin regimen (moxifloxacin [M], isoniazid [H], rifampicin [R], pyrazinamide [Z], ethambutol [E]) or the control regimen (RHZE thrice weekly). Bacteriological assessments were done at 15, 30, 45, and 60 days of treatment. Because all patients in the moxifloxacin groups received 2 months of daily RHZEM, they were grouped together for analysis. Statistical methods included χ(2) test and logistic regression analysis. RESULTS: Sputum culture conversion was analyzed in 780 (616 in the moxifloxacin group and 164 in the control group) of 801 enrolled patients. Ninety-five percent of 590 patients in the moxifloxacin group and 81% of 151 patients in the control group had negative sputum cultures at month 2 (P < .001). The control regimen, age (≥35 years), initial sputum culture grade (2+ or 3+), and male sex were significantly associated with higher odds of positive sputum cultures at 2 months. CONCLUSIONS: A 5-drug daily regimen with moxifloxacin results in significantly higher sputum culture conversion in the first 2 months compared with a thrice-weekly, 4-drug regimen in patients with newly diagnosed sputum-positive pulmonary tuberculosis.


Assuntos
Antituberculosos/uso terapêutico , Fluoroquinolonas/uso terapêutico , Escarro/microbiologia , Tuberculose Pulmonar/diagnóstico , Tuberculose Pulmonar/tratamento farmacológico , Adulto , Antituberculosos/administração & dosagem , Antituberculosos/efeitos adversos , Esquema de Medicação , Farmacorresistência Bacteriana , Quimioterapia Combinada , Feminino , Fluoroquinolonas/administração & dosagem , Fluoroquinolonas/efeitos adversos , Seguimentos , Humanos , Índia , Masculino , Pessoa de Meia-Idade , Moxifloxacina , Radiografia Torácica , Sistema de Registros , Fatores de Risco , Resultado do Tratamento , Adulto Jovem
2.
Int Sch Res Notices ; 2014: 798934, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-27437455

RESUMO

Extensive research happening across the globe witnessed the importance of Wireless Sensor Network in the present day application world. In the recent past, various routing algorithms have been proposed to elevate WSN network lifetime. Clustering mechanism is highly successful in conserving energy resources for network activities and has become promising field for researches. However, the problem of unbalanced energy consumption is still open because the cluster head activities are tightly coupled with role and location of a particular node in the network. Several unequal clustering algorithms are proposed to solve this wireless sensor network multihop hot spot problem. Current unequal clustering mechanisms consider only intra- and intercluster communication cost. Proper organization of wireless sensor network into clusters enables efficient utilization of limited resources and enhances lifetime of deployed sensor nodes. This paper considers a novel network organization scheme, energy-efficient edge-based network partitioning scheme, to organize sensor nodes into clusters of equal size. Also, it proposes a cluster-based routing algorithm, called zone-based routing protocol (ZBRP), for elevating sensor network lifetime. Experimental results show that ZBRP out-performs interims of network lifetime and energy conservation with its uniform energy consumption among the cluster heads.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...